In terms of lung cancer, a recent study reported that patients with non-small-cell lung carcinomas (NSCLCs) exhibited MARS overexpression in tumor cells, and that poor clinical outcomes were closely associated with the MARS staining intensity and proportion [9]. The gene discussed is MARS1; the disease is lung carcinoma.